Apollo Endosurgery Long Term Debt

As of the most recent data (December 2022), APEN shows a long-term debt of $37M. That compares with $53M in the prior-year period — down 30.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APEN's long-term debt is now $37M (was $53M) — a 30.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Apollo Endosurgery is outperforming or lagging.

Tracking APEN's long-term debt over time shows whether Apollo Endosurgery is scaling, shrinking, or reshaping that part of the business. The current reading is $37M That compares with $53M in the prior-year period — down 30.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Apollo Endosurgery's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $37M) with ownership activity and broader fundamentals.

Apollo Endosurgery's long-term debt is $37M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.